Johnson & Johnson (JNJ) Price Target Up at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
- SanDisk upgraded at JPMorgan after investor day; shares climb
BMO Capital Reiterates Outperform on Johnson & Johnson (JNJ) Following 2Q Report
July 20, 2016 10:39 AM EDTBMO Capital reiterated an Outperform rating and $132.00 price target on Johnson & Johnson (NYSE: JNJ) following the company's 2Q earnings report. JNJ reported revenue of $18.48B, ahead of the consensus estimate of $17.98 billion. EPS of $1.74 was also above the consensus estimates at $1.68.
Analyst Joanne... More
